Preview

Concept Life Sciences Acquires CXR Biosciences To Augment Its Expanding Service Base In Discovery And PreClinical Sciences

Satisfactory Essays
Open Document
Open Document
769 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Concept Life Sciences Acquires CXR Biosciences To Augment Its Expanding Service Base In Discovery And PreClinical Sciences
PressReleasePing

Concept Life Sciences acquires CXR
Biosciences to augment its expanding service base in Discovery and PreClinical
Sciences
LONDON: Concept Life Sciences, scientific Laboratory and consultancy group has acquired
CXR Biosciences. This marks its fourth acquisition since it was formed in July 2014. Led by
Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan the Concept Life
Sciences Group currently has over 600 staff in 11 core locations, with advanced plans for further expansion into continental Europe.
LONDON, UK, August 19, 2015 /PressReleasePing/ - Concept Life Sciences, scientific
Laboratory and consultancy group has acquired CXR Biosciences. This marks its fourth acquisition since it was formed in July 2014. Led by Executive Chairman Michael Fort and
Chief Executive Officer Alan Morgan tnhe Concept Life Sciences Group currently has over
600 staff in 11 core locations, with advanced plans for further expansion into continental
Europe.

CXR Biosciences is a leading investigative toxicology business. Its in-house expertise assists international life sciences companies to resolve issues relating to the safety of compounds and with the selection of drug and chemical candidates. The company was eyed as an acquisition target as it complements Concept Life Sciences’ existing platform of problem solving chemical synthesis and biological services. The acquisition of CXR Biosciences further strengthens Concept Life Sciences’ portfolio offering and enhances its ability to support its customer’s complex discovery projects.

The CXR Biosciences team comprises staff from both industrial and academic backgrounds; over 50 per cent of whom have PhDs bringing Concept’s total number of PhDs to over 120.
CXR Biosciences will retain its name and operate under the Concept Life Sciences Group umbrella. All staff including the management team will be joining the Concept Life Sciences’
Group. CXR Biosciences CEO, Paul Smith will continue to head up the

You May Also Find These Documents Helpful

  • Good Essays

    Bear Stearns Case Summary

    • 427 Words
    • 2 Pages

    In the 1940’s, the firm became a large player in mergers and acquisitions, particularly in the…

    • 427 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    Mha 616 Wk 5 Dq 2

    • 398 Words
    • 2 Pages

    The acquisition process involved a project steering committee that consisted with Dr. Brown as the lead who appointed a senior physician, Dr. Ward, the CEO, Mr. Rowls; a registered nurse, Ms. Matthews and the business office manager, Ms. Raymond. A member of the Regional Extension Center (REC), Ms. Moore was approved by the physicians to be included in the committee to guide them through the process. Dr. Marcus, lead physician along with six others physicians gave and received feedback on progress throughout the acquisition process according to (Wagner, Lee, & Glaser 2013).…

    • 398 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    There are a few barriers to market entry. Acquiring qualified chemists for innovation may be a challenge.…

    • 353 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    public offering (IPO) a few months ago. John Sigar is the current CEO and member of the…

    • 1068 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    Kmart History Timeline

    • 2033 Words
    • 9 Pages

    2002 - Chuck Conaway resigned as Chairman and CEO as board member James B. Adamson was appointed to serve as the company's new Chairman and Chief Executive Officer. Julian C. Day was appointed President and Chief Operating Officer.…

    • 2033 Words
    • 9 Pages
    Good Essays
  • Satisfactory Essays

    Sirtris

    • 574 Words
    • 3 Pages

    * • Partnership with Pharma. As is almost always the case in biotech, the team was in…

    • 574 Words
    • 3 Pages
    Satisfactory Essays
  • Powerful Essays

    It is considered to be a Family Company as it globes more than 230 subsidiaries. This “Family” comprises:…

    • 1780 Words
    • 8 Pages
    Powerful Essays
  • Good Essays

    As of today, the department has over 250 trainees, two ACGME Fellowship programs, as well as a Cardiac Fellowship (est. 2012), Palliative Fellowship (est. 2015), and a Pain Fellowship (est.2011).…

    • 408 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    Drug Companies and Ethics

    • 656 Words
    • 3 Pages

    I found researching the pharmaceutical companies to be very interesting. It was very hard to get past the negative controversies and debates to find anything positive about any one company. However, I finally found one company in particular, Merck & Co. that has taken responsibility and turned around some negative press by developing a program that helps thousands of people.…

    • 656 Words
    • 3 Pages
    Satisfactory Essays
  • Better Essays

    Gmo Lab Report

    • 2784 Words
    • 12 Pages

    Sylvia R. M. Broeders, Sigrid C. J. De Keersmaecker, and Nancy H. C. Roosen. "How to Deal with the Upcoming Challenges in." Journal of Biomedicine and Biotechnolog (2012): 11.…

    • 2784 Words
    • 12 Pages
    Better Essays
  • Good Essays

    knew that the drug would probably never see commercial use. Investing millions of dollars in…

    • 790 Words
    • 4 Pages
    Good Essays
  • Satisfactory Essays

    Assessment 1 Ethics

    • 332 Words
    • 2 Pages

    The first recorded numbers were 1300 members in 1982-3 and have grown to more than 50 000 members in 2007. The BSC has been awarded many statuses thought its lifetime and is one of the biggest names in IT.…

    • 332 Words
    • 2 Pages
    Satisfactory Essays
  • Better Essays

    Clinical Trial and Vertex

    • 1629 Words
    • 7 Pages

    Vertex faced a very difficult decision when the company had to decide which drug candidates they should fund on their own, and which ones they should partner up with cooperate alliances who can financial support the projects. The company had revenue from various corporate partnerships and roughly $600 million in cash and short-term investments, but the company would not be able to fund more that two of its fours primary development projects. The decision was colossal since the chosen candidates would be the first products Vertex attempted to bring through development and hopefully onto the market on its own (Pisano).…

    • 1629 Words
    • 7 Pages
    Better Essays
  • Powerful Essays

    The organization had utilized around 350 to 400 lasting specialists with an extra 80-100 learners/disciples. An extra 500 specialists were later enlisted utilizing work foremen who are for every viable purpos, nearby…

    • 1230 Words
    • 5 Pages
    Powerful Essays
  • Powerful Essays

    |25, 000, spread over 308 Campus groups nationwide. If we are going to transform the nation from the campus; numerical growth must not be |…

    • 1480 Words
    • 6 Pages
    Powerful Essays